ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Patient Finding Is One of the Most Common Uses of Machine Learning Within Commercial Operations in Biopharma

September 27, 2021 GMT

WALTHAM, Mass.--(BUSINESS WIRE)--Sep 27, 2021--

Trinity Life Sciences, a leader in global life sciences commercialization solutions, finds that 45 percent of all machine learning use cases within biopharma companies are for finding patients. According to the new TGaS report entitled AIML Use Case Landscape Report, within patient finding applications, 75 percent are designed to enhance health care provider (HCP) targeting or develop HCP alerts.

“If a life sciences company is not doing patient finding alerts/targeting with machine learning, they are probably behind the industry,” said Steve Laux, Vice President, Artificial Intelligence & Machine Learning at TGaS Advisors, a division of Trinity Life Sciences. “It is clear that patient finding can have a big impact. Biopharma executives may be surprised to learn that it is more feasible and practical than they think.”

ADVERTISEMENT

The report also includes separate use cases on machine learning for:

  • Alerts
  • Commercial Analytics
  • Field Operations
  • Health Care Provider (HCP) Targeting
  • Marketing Operations/Contracting
  • Medical Affairs
  • Orchestrated Engagement/Non-Personal Promotion
  • Other Commercial Uses

Trinity is hosting an upcoming webinar on the topic entitled “Everything You Wanted to Know About Patient Finding but Were Afraid to Ask – Focus on Commerical Applications” on September 29 at 1 p.m. ET. Key topics that will be addressed include:

With a roster of large, emerging, and precommercial life sciences companies, TGaS Advisors, a division of Trinity, provides robust comparative intelligence and collaborative network membership services.

ADVERTISEMENT

Media interested in receiving a copy of the report should contact Elizabeth Marshall at EMarshall@trinitylifesciences.com.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210927005100/en/

CONTACT: Elizabeth Marshall

Trinity Life Sciences

781-577-6376

emarshall@trinitylifesciences.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: BIOTECHNOLOGY SCIENCE HEALTH OTHER SCIENCE

SOURCE: Trinity Life Sciences

Copyright Business Wire 2021.

PUB: 09/27/2021 08:37 AM/DISC: 09/27/2021 08:37 AM

http://www.businesswire.com/news/home/20210927005100/en